Welcome to visit Zhongnan Medical Journal Press Series journal website!

Home Articles Vol 27,2024 No.6 Detail

The effect of seritaline and multidisciplinary collaborative management model on adolescents with first-episode major depression disorder

Published on Jul. 02, 2024Total Views: 1097 times Total Downloads: 279 times Download Mobile

Author: RU Guifang LI Yuanlin GAO Min

Affiliation: Department of Psychiatry, Third People's Hospital of Fuyang City, Fuyang 236000, Anhui Province, China

Keywords: Major depressive disorder Sertraline Multidisciplinary collaborative management model Emotion Inflammatory factor

DOI: 10.12173/j.issn.1008-049X.202403205

Reference: RU Guifang, LI Yuanlin, GAO Min.The effect of seritaline and multidisciplinary collaborative management model on adolescents with first-episode major depression disorder[J].Zhongguo Yaoshi Zazhi,2024, 27(6):999-1006.DOI: 10.12173/j.issn.1008-049X.202403205.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective  To explore the clinical efficacy of escitalopram combined with multidisciplinary collaborative management model (MCMM) on adolescents with first-episode major depressive disorder (MDD).

Methods  Two hundred adolescents with first-episode MDD who admitted to Fuyang Third People's Hospital, Anhui Province, from January 2019 to November 2023, were selected as study participnts. They were randomly divided into a control group and a MCMM group. Both groups of patients received sertraline hydrochloride tablets and routine psychiatric care for 8 weeks. Additionally, the MCMM group received an MCMM intervention on this basis. The clinical efficacy of the interventions, pre- and post-treatment assessments included clinical scale data [Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), and Connor-Davidson Resilience Scale (CD-RISC)], inflammatory factors [interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α)], neurotrophin factors [serotonin (5-hydroxytryptamine, 5-HT) and glial cell-derived neurotrophic factor (GDNF)] were compared between the two groups.

Results  Before the intervention, there were no statistical differences in the clinical scale data, inflammatory factors and neurotrophic factors between the two groups (P>0.05). After 8 weeks of intervention, the HAMD score, HAMA score, serum IL-1β, IL-6, TNF-α, 5-HT, and GDNF levels significantly decreased compared with pre-intervention (P<0.05), while the CD-RISC score significantly increased (P<0.05). In addition, the MCMM group showed greater reductions in HAMD, HAMA, IL-1β, IL-6, TNF-α, 5-HT, and GDNF levels and a greater increase in CD-RISC score compared to the control group (P<0.05).

Conclusion  Compared with sertraline combined with routine care, MCMM significantly alleviates anxiety and depression, enhances psychological resilience, and reduces inflammation in MDD patients.

Full-text
Please download the PDF version to read the full text: download
References

1.左红霞, 柯玉芳, 汪龙, 等. 帕罗西汀联合奥氮平对我国抑郁症合并睡眠障碍患者临床疗效的Meta分析 [J]. 药物流行病学杂志, 2024, 33(4): 422-440. [Zuo  HX, Ke  YF, Wang L, et al. Meta-analysis of the clinical efficacy of paroxetine combined with olanzapine in patients with depression and sleep disorders in China[J]. Chinese Journal of Pharmacoepidemiology, 2024, 33(4): 422-440.] DOI: 10.12173/j.issn.1005-0698.202308030.

2.周鹏飞, 杨孝光, 路强, 等. 中国农村老年人群抑郁症患病率的Meta分析[J]. 中国循证医学杂志, 2024, 24(1): 36-42. [Zhou PF, Yang XG, Lu Q, et al. Meta-analysis of the prevalence of depression in the elderly population in rural China[J]. Chinese Journal of Evidence-Based Medicine, 2024, 24(1): 36-42.] DOI: 10.7507/1672-2531.202304113.

3.Salk RH, Hyde JS, Abramson LY. Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms[J]. Psychol Bull, 2017, 143(8): 783-822. DOI: 10.1037/bul0000102.

4.Su YA, Ye C, Xin Q, et al. Major depressive disorder with suicidal ideation or behavior in Chinese population: a scoping review of current evidence on disease assessment, burden, treatment and risk factors[J]. J Affect Disord, 2023, 340: 732-742. DOI: 10.1016/j.jad.2023.08.106.

5.龚莹莹, 江庐山, 姜庆伟. 间歇性θ短阵快速脉冲刺激在精神心理疾病治疗中的研究进展[J]. 华西医学, 2024, 39(4): 654-659. [Gong YY, Jiang LS, Jiang  QW. Advances in the research of intermittent theta burst stimulation in the treatment of mental and psychological disorders[J]. West China Medical Journal, 2024, 39(4): 654-659.] DOI: 10.7507/1002-0179.202310227.

6.Buckman JEJ, Underwood A, Clarke K, et al. Risk factors for relapse and recurrence of depression in adults and how they operate: a four-phase systematic review and Meta-synthesis[J]. Clin Psychol Rev, 2018, 64: 13-38. DOI: 10.1016/j.cpr.2018.07.005.

7.李承美, 倪纯纯, 肖玉昐. 团体叙事心理干预对青少年抑郁症患者的影响[J]. 护理学杂志, 2023, 38(10): 86-89. [Li CM, Ni CC, Xiao YX. The impact of group narrative psychological intervention on adolescent depression patients[J]. Journal of Nursing Science, 2023, 38(10): 86-89.] DOI: 10.3870/j.issn.1001-4152.2023.10.086.

8.丁晓春. 电针疗法联合舍曲林治疗中重度抑郁症临床研究[J]. 中西医结合研究, 2023, 15(6): 361-364. [Ding XC. Clinical study on electroacupuncture therapy combined with sertraline in the treatment of moderate to severe depression[J]. Research of Integrated Traditional Chinese and Western Medicine, 2023, 15(6): 361-364.] DOI: 10.3969/j.issn.1674-4616.2023.06.001.

9.张淑婷, 沈悦娣, 刘兆宇. 重复经颅磁刺激对抑郁症病人认知功能影响的研究进展[J]. 护理研究, 2023, 37(21): 3886-3889. [Zhang ST, Shen  YD, Liu  ZY. Research progress on the influence of repetitive transcranial magnetic stimulation on cognitive function in patients with depression[J]. Chinese Nursing Research, 2023, 37(21): 3886-3889.] DOI: 10.12102/j.issn.1009-6493.2023.21.016.

10.乔海芹, 张鹤立, 李佩涛, 等. 护士主导的多学科协作管理模式在骨科手术患者院前管理中的实践 [J]. 中国护理管理, 2023, 23(11): 1622-1625. [Qiao  HQ, Zhang  HL, Li PT, et al. Practice of nurse-led multidisciplinary collaboration management model in pre-hospital management of orthopedic surgery patients[J]. Chinese Nursing Management, 2023, 23(11): 1622-1625.] DOI: 10.3969/j.issn.1672-1756.2023.11.005.

11.陈玉兰. 多学科协作护理新模式对慢性阻塞性肺疾病患者肺功能及护理效果的影响[J]. 中国医药指南, 2024, 22(7): 135-138. [Chen YL. The influence of the new model of multidisciplinary collaborative care on lung function and nursing outcomes in patients with chronic obstructive pulmonary disease[J]. Chinese Medicine Guide, 2024, 22(7): 135-138.] DOI: 10.15912/j.issn.1671-8194. 2024.07.039.

12.尹建红, 刘鸣, 李米娜, 等. 基于多学科团队诊疗模式的医护联合管理在糖尿病足病人中的应用效果[J]. 护理研究, 2023, 37(23): 4307-4313. [Yin JH, Liu M, Li  MN, et al. Application effect of medical and nursing joint management based on multidisciplinary team diagnosis and treatment model in patients with diabetes foot[J]. Chinese Nursing Research, 2023, 37(23): 4307-4313] DOI: 10.12102/j.issn.1009-6493.2023.23.027.

13.李功迎, 宋思佳, 曹龙飞. 精神障碍诊断与统计手册第5版解读[J]. 中华诊断学电子杂志, 2014, 2(4): 310-312. [Li GY, Song SJ, Cao LF. Interpretation of the fifth edition of the diagnostic and statistical manual of mental disorders[J]. Chinese Journal of Diagnostics (Electronic Edition), 2014, 2(4): 310-312.] DOI: 10.3877/cma.j.issn.2095-655X.2014.04.017.

14.刘寰, 康莉, 姚媛, 等. 多学科协作护理管理模式在抑郁症病人中的应用效果[J]. 护理研究, 2023, 37(23): 4321-4326. [Liu H, Kang L, Yao Y, et al. The application effect of multidisciplinary collaborative nursing management model in patients with depression[J]. Chinese Nursing Research, 2023, 37(23): 4321-4326.] DOI: 10.12102/j.issn.1009-6493.2023.23.029.

15.胡旭强, 钱敏才, 林敏, 等. 斯奈思-汉密尔顿快感量表中文版测评抑郁症患者的效度和信度[J]. 中国心理卫生杂志, 2017, 31(8): 625-629. [Hu XQ, Qian MC, Lin M, et al. Validity and reliability of the Chinese version of the Snaith-Hamilton Pleasure Scale in evaluating depressed patients[J]. Chinese Mental Health Journal, 2017, 31(8): 625-629.] DOI: 10.3969/j.issn.1000-6729. 2017.08.008.

16.Rosenberg LI. The Ham-D is not Hamilton's Depression Scale[J]. Psychopharmacol Bull, 2022, 52(2): 117-153. https://pubmed.ncbi.nlm.nih.gov/35721817/.

17.孟佳乐, 孔韵怡, 沈梦圆, 等. 基于主体-客体互倚模型分析居家失能老人及照顾者照护能力与心理弹性的关系[J]. 护理研究, 2024, 38(9): 1550-1555. [Meng  JL, Kong YY, Shen MY, et al. Analysis of the relationship between the caregiving ability and psychological resilience of home-based disabled elderly and caregivers based on the subject-object interdependence model[J]. Chinese Nursing Research, 2024, 38(9): 1550-1555.] DOI: 10.12102/j.issn.1009-6493.2024.09.007.

18.Choi KW, Kim YK, Jeon HJ. Comorbid anxiety and depression: clinical and conceptual consideration and transdiagnostic treatment[J]. Adv Exp Med Biol, 2020, 1191: 219-235. DOI: 10.1007/978-981-32-9705-0_14.

19.李瑾. 积极心理学在中职思政课教育实践中的应用探究[J]. 现代商贸工业, 2024, 45(5): 247-249. [Li  J. Application of positive psychology in the educational practice of ideological and political education in secondary vocational schools[J]. Modern Business Trade Industry, 2024, 45(5): 247-249.] DOI: 10.19311/j.cnki.1672-3198. 2024.05.082. DOI: 10.27036

20.宁林娇. 童年期心理虐待对农村高中生抑郁情绪的影响: 反刍思维和心理弹性的作用及干预[D]. 广西桂林: 广西师范大学, 2023. DOI: 10.27036/d.cnki.ggxsu.2023. 001806.

21.向娇娇, 洪素, 冉柳毅, 等. 舍曲林对首发重度抑郁症青少年患者血清炎症因子的影响研究[J]. 四川大学学报(医学版), 2023, 54(2): 310-315. [Xiang  JJ, Hong S, Ran LY, et al. Effect of sertraline on serum inflammatory factors in adolescents with first-episode major depressive disorder[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(2): 310-315.] DOI: 10.12182/202303 60204.

22.冯毅菲, 张培文, 曹美群. 抑郁症患者TNF-α和ADP比值的研究[J]. 重庆医学, 2024, 53(5): 696-699, 706. [Feng YF, Zhang PW, Cao MQ. Study on the ratio of TNF-α and ADP in patients with depression[J]. Chongqing Medicine, 2024, 53(5): 696-699, 706.] DOI: 10.3969/j.issn.1671-8348.2024.05.010.

23.吴梦迪, 刘黎明, 苏攀, 等. 从神经炎症角度论丹栀逍遥散抗抑郁作用机制的研究进展[J]. 中草药, 2024, 55(7): 2442-2451. [Research progress on the antidepressant mechanism of Danzhi Xiaoyao Powder from the perspective of neuroinflammation[J]. Chinese Traditional and Herbal Drugs, 2024, 55(7): 2442-2451.] DOI: 10.7501/j.issn.0253-2670.2024.07.030.

24.林洁筠, 段阳, 龙淼青, 等. 柴胡疏肝散在抗抑郁治疗中的药效物质与作用机制研究进展[J]. 中国实验方剂学杂志, 2024, 30(10): 246-257. [Lin JY, Duan Y, Long MQ, et al. Progress in the study of pharmacodynamic substances and mechanism of action of Chaihu Shugan powder in the treatment of depression[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2024, 30(10): 246-257.] DOI: 10.13422/j.cnki.syfjx.20240117.

25.吴迪, 陈应靖, 李媛, 等. 艾地苯醌联合舍曲林对抑郁症认知损害的早期改善作用[J]. 实用临床医药杂志, 2021, 25(1): 97-99, 103. [Wu D, Chen YJ, Li Y, et al. Early improvement of cognitive impairment in depression by combination therapy of idebenone and sertraline[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 97-99, 103.] DOI: 10.7619/jcmp.20200814.

26.姚娇, 杨岩涛, 艾启迪, 等. 神经递质功能与抑郁症发病的研究进展[J]. 中国药理学通报, 2023, 39(7): 1217-1221. [Yao J, Yang YT, Ai QD, et al. Advances in the study of neurotransmitter function and the pathogenesis of depression[J]. Chinese Pharmacological Bulletin, 2023, 39(7): 1217-1221.] DOI: 10.12356/CPB202204076.

Popular papers
Last 6 months